Your account is not claimed yet. You can sign up with ORCID to claim your account.

Torben Plesner

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

British journal of haematology

Clinical hematology international

Journal of clinical medicine

Cells

Vejle Hospital

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Vejle Hospital Oct 1o 2000

Denmark

Professor :: Hematology

Publications

Torben Plesner, Simon J Harrison, Hang Quach, Cindy Lee, Adam Bryant, Annette Vangsted, Jane Estell, Michel Delforge, Fritz Offner, Patrick Twomey, Voleak Choeurng, Junyi Li, Robert Hendricks, Shannon M Ruppert, Teiko Sumiyoshi, Karen Miller, Eunpi Cho, Fredrik Schjesvold
Phase I Study of Safety and Pharmacokinetics of RO7297089, an Anti-BCMA/CD16a Bispecific Antibody, in Patients with Relapsed, Refractory Multiple Myeloma. Clinical hematology international (2023)
Kieran Brennan, Katrine Fladeland Iversen, Alfonso Blanco-Fernández, Thomas Lund, Torben Plesner, Margaret M Mc Gee
Extracellular Vesicles Isolated from Plasma of Multiple Myeloma Patients Treated with Daratumumab Express CD38, PD-L1, and the Complement Inhibitory Proteins CD55 and CD59. Cells 11 (21) (2022)
Torben Plesner
Optimizing the Outcome of Anti-Myeloma Treatment with Daratumumab. Journal of clinical medicine 10 (5) (2021)
Torben Plesner, Meletios- Athanasios Dimopoulos, Albert Oriol, Jesús San F Miguel, Nizar J Bahlis, Neil Rabin, Kenshi Suzuki, Sung-Soo Yoon, Dina Ben-Yehuda, Curly T C M Morris, Hartmut Goldschmidt, Sebastian Grosicki, Xiang Qin, John Fastenau, Wendy Garvin, Robin Carson, Thomas Renaud, Katharine S Gries
Health-related quality of life in patients with relapsed or refractory multiple myeloma: treatment with daratumumab, lenalidomide, and dexamethasone in the phase 3 POLLUX trial. British journal of haematology 194 (1) (2021)
Sara Bringhen, Peter M Voorhees, Torben Plesner, Ulf-Henrik Mellqvist, Brandi Reeves, Pieter Sonneveld, Catriona Byrne, Eva Nordström, Johan Harmenberg, Jakob Obermüller, Paul Gerard Richardson
Melflufen plus dexamethasone in relapsed/refractory multiple myeloma: long-term survival follow-up from the Phase II study O-12-M1. British journal of haematology 193 (6) (2021)
Torben Plesner, Hendrik-Tobias Arkenau, Francesca Gay, Monique C Minnema, Mario Boccadoro, Phillipe Moreau, Jamie Cavenagh, Aurore Perrot, Jacob P Laubach, Jakub Krejcik, Tahamtan Ahmadi, Carla de Boer, Diana Chen, Christopher Chiu, Jordan M Schecter, Paul Gerard Richardson
Enduring efficacy and tolerability of daratumumab in combination with lenalidomide and dexamethasone in patients with relapsed or relapsed/refractory multiple myeloma (GEN503): final results of an open-label, phase 1/2 study. British journal of haematology 186 (3) (2019)
Torben Plesner
"Fine-tuning cytoreduction in resistant multiple myeloma - progress here, too"? British journal of haematology 187 (3) (2019)

Torben Plesner.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Torben Plesner